HETERO LABS LTD III FDA Approval ANDA 204993

ANDA 204993

HETERO LABS LTD III

FDA Drug Application

Application #204993

Application Sponsors

ANDA 204993HETERO LABS LTD III

Marketing Status

Prescription001
Prescription002

Application Products

001TABLET;ORAL200MG0RUFINAMIDERUFINAMIDE
002TABLET;ORAL400MG0RUFINAMIDERUFINAMIDE

FDA Submissions

UNKNOWN; ORIG1AP2021-05-11STANDARD

Submissions Property Types

ORIG1Null1

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

HETERO LABS LTD III
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 204993
            [companyName] => HETERO LABS LTD III
            [docInserts] => ["",""]
            [products] => [{"drugName":"RUFINAMIDE","activeIngredients":"RUFINAMIDE","strength":"200MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"RUFINAMIDE","activeIngredients":"RUFINAMIDE","strength":"400MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"05\/11\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-05-11
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.